Eur Rev Med Pharmacol Sci 2022; 26 (8): 2647-2647
DOI: 10.26355/eurrev_202204_28592

Author Correction: Correlation between expression levels of lncRNA UCA1 and miR-18a with prognosis of hepatocellular cancer

Z. Zhang, J.-Z. Li, Z.-W. Wei, F. Li, H.-M. Li, Y. Xiao, Y.-Q. Qin

Departments of Hepatobiliary Surgery, The Fifth Affiliated Hospital of Guangxi Medical University, Nanning, China


Correction to: European Review for Medical and Pharmacological Sciences 2020; 24 (7): 3586-3591–DOI: 10.26355/eurrev_202004_20820–PMID: 32329833, published online on 15 April 2020.

After publication, the authors noticed some mistakes in the manuscript and applied to issue the following changes: the legend of Table I, the date of enrollment of the patients in the section titled “Baseline Characteristics of HCC Patients”, the date of follow-up reported in the abstract and in the section entitled “Postoperative Follow-Up”.

The authors also applied to modify the survival curve of Figure 3 due to misuse of data in the statistical analysis.

There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause.

https://www.staging.europeanreview.org/article/20820

Free PDF Download

To cite this article

Z. Zhang, J.-Z. Li, Z.-W. Wei, F. Li, H.-M. Li, Y. Xiao, Y.-Q. Qin
Author Correction: Correlation between expression levels of lncRNA UCA1 and miR-18a with prognosis of hepatocellular cancer

Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 8
Pages: 2647-2647
DOI: 10.26355/eurrev_202204_28592